Vasopressin and Steroids in addition to Adrenaline in cardiac arrest -a randomized clinical trial

Status

Withdrawn

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500137-89-00

Enrollment

1400

Registered

2022-03-28

Start date

2022-12-19

Completion date

Unknown

Last updated

2022-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac arrest

Brief summary

Survival at 30 days

Interventions

DRUGSolu-Medrol 40 mg pulver och vätska till injektionsvätska

DRUGlösning

DRUGAdrenalin Aguettant 0

DRUG1 mg/ml

DRUGinjektionsvätska

DRUGlösning i förfylld spruta

DRUGEmpressin 40 IE/2 ml koncentrat till infusionsvätska

DRUGSolu-Cortef 100 mg pulver och vätska till injektionsvätska

DRUGlösning.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Survival at 30 days	—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026